CryoCor: Corporate Profile: Intellectual Property

Business Opportunity

Problem – Solution

Procedure

Intellectual Property

Home > Corporate Profile > Intellectual Property

INTELLECTUAL PROPERTY

CryoCor has built a portfolio of proprietary technologies in the design, function and performance of its System allowing for protected pursuit of its business strategy in successfully treating various cardiac arrhythmias, for which patents will be assigned to the Company. CryoCor's comprehensive intellectual property (IP) portfolio provides a formidable barrier of entry due to its proprietary position in the application of cryothermy to achieve and maintain sufficiently low temperatures to safely and effectively treat atrial fibrillation, atrial flutter and other cardiac arrhythmias.

Currently, CryoCor owns or licenses 39 issued United States patents and a number of pending United States patent applications covering various aspects of our products and technology. The Company also owns or licenses 24 patents issued outside of the United States and has a number of pending patent applications outside the United States.